EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PET imaging of TREM2 in amyloid-beta induced neuroinflammation

Amelia D Dahlén iD, Sahar Roshanbin iD, Ximena Aguilar iD, Nadja M Bucher iD, Sara Lopes van den Broek iD, Dag Sehlin iD, Stina Syvänen iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07358-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Amelia D Dahlén und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Caring Sciences, Section of Molecular Geriatrics, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Membrane Glycoproteins, Receptors, Immunologic, Amyloid beta-Peptides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The triggering receptor expressed on myeloid cells 2 (TREM2) has become a promising target for biologics in both monitoring and treating neuroinflammation in Alzheimer’s disease (AD). This study aimed to develop and compare bispecific anti-TREM2 antibodies featuring different transferrin receptor (TfR) binders to enhance brain delivery, identifying the most suitable format for in vivo PET imaging of TREM2 in transgenic AD mice.

Methods

Three bispecific TREM2-antibody formats were produced and evaluated for their ability to cross the blood-brain barrier (BBB) via TfR-mediated transcytosis and bind TREM2. Blood concentration profiles up to 72 h post-injection (p.i.), and ex vivo brain uptake of iodine-125-labeled antibody constructs were quantified in App NL−G−F and age-matched wild type (WT) mice using a γ-counter. The best-performing bispecific TREM2-antibody was radiolabeled with iodine-124 and used for in vivo PET imaging of brain TREM2 levels in App NL−G−F mice at 72 h p.i. Brain TREM2 concentrations were subsequently quantified using ELISA.

Results

The antibody format carrying two scFv8D3 TfR-binders (IgG-scFv 2 ), demonstrated the highest brain concentrations of all tested bispecific constructs. This antibody also exhibited significantly higher brain concentrations in App NL−G−F mice compared to WT mice at both 48 and 72 h p.i. This difference was further visualized and quantified through in vivo PET imaging. Moreover, brain concentrations of the antibody ligand correlated with elevated TREM2 levels in brain homogenates.

Conclusion

These findings highlight IgG-scFv 2 as a promising radioligand for in vivo PET imaging of TREM2, advancing non-invasive neuroinflammation studies and supporting drug development for AD and other neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyMembrane GlycoproteinsReceptors, ImmunologicAmyloid beta-PeptidesNeuroinflammatory DiseasesAnimalsMiceBrainHumansMice, TransgenicReceptors, TransferrinAntibodies, BispecificIodine Radioisotopes

Stichwörter der Autor:innen

Alzheimer’s diseaseAntibody-based PETBispecific antibodyNeuroinflammationThe blood-brain barrier

Substanzen

Membrane GlycoproteinsReceptors, ImmunologicTrem2 protein, mouseAmyloid beta-PeptidesReceptors, TransferrinAntibodies, BispecificIodine Radioisotopes

Autor:innen und Institutionen

  • Department of Public Health and Caring Sciences, Section of Molecular Geriatrics, Uppsala University, Uppsala, Sweden.
  • Department of Public Health and Caring Sciences, Section of Molecular Geriatrics, Uppsala University, Uppsala, Sweden. stina.syvanen@uu.se.

ORCID-Profile: Amelia D Dahlén, Sahar Roshanbin, Ximena Aguilar, Nadja M Bucher, Sara Lopes van den Broek, Dag Sehlin, Stina Syvänen

Förderung

  • Uppsala University

Zitieren

APA

Dahlén, A. D., Roshanbin, S., Aguilar, X., Bucher, N. M., Lopes van den Broek, S., Sehlin, D., & Syvänen, S. (2025). PET imaging of TREM2 in amyloid-beta induced neuroinflammation. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07358-0

Vancouver

Dahlén AD, Roshanbin S, Aguilar X, Bucher NM, Lopes van den Broek S, Sehlin D, et al. PET imaging of TREM2 in amyloid-beta induced neuroinflammation. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07358-0

BibTeX
@article{Dahln2025,
  author = {Dahlén, Amelia D and Roshanbin, Sahar and Aguilar, Ximena and Bucher, Nadja M and Lopes van den Broek, Sara and Sehlin, Dag and Syvänen, Stina},
  title = {PET imaging of TREM2 in amyloid-beta induced neuroinflammation},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07358-0}
}
Kostenlos starten →